ImmuPharma plc (IMM.L) LSE
6.98
+0.34(+5.12%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
6.98
+0.34(+5.12%)
Currency In GBp
| Market Cap | 5.01M |
| Enterprise Value | 4.77M |
| P/E Ratio | -8.51 |
| PEG Ratio | 0.45 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 99.48 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -11.31 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.49 |
| Return On Equity | 38.17 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -63,880 |
| EBITDA | -2.61M |
| Net Income | -2.48M |
| Diluted EPS | -0.01 |
| Total Cash | 396,648 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.21 |
| Book Value Per Share | 0 |
| 52-Week Change | 112.16 |
| 52-Week High | 19.4 |
| 52-Week Low | 1.39 |
| Moving Average 50 Days | 7.11 |
| Moving Average 200 Days | 6.48 |
| Average Volume | 3.2M |
| Shares Outstanding | 502.72M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |